You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Application of ivivr in the development of generic transdermal drug delivery system: a case study of rivastigmine
- In: Posters D - Formulation Design and Pharmaceutical Technology
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PD-034
- By: EAGA, Chandra Mohan (Hyderabad, India)
- Co-author(s): Aggarwal, Deepika (Dr Reddys Laboratories, Hyderabad, India)
Pk, Ruby (Dr Reddys Laboratories, Hyderabad, India)
Malayandi, Rajkumar (Dr Reddys Laboratories, Hyderabad, India) - Abstract:
Background: Transdermal therapeutic drug delivery systems have been gained more importance in recent years, especially for the delivery of CNS agents, pain management, hormones etc. Rivastigmine, a centrally acting acetylcholine esterase inhibitor is used in the treatment of dementia associated with Alzhemer's disease and Parkinsonism. Oral..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026